News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Amol Akhade: P53 for endometrial cancer
Amol Akhade/LinkedIn
Jun 23, 2024, 14:41

Amol Akhade: P53 for endometrial cancer

Amol Akhade, Consultant Medical Oncologist atSuyog Cancer Clinics, shared a post on X:

“P53 for endometrial cancer. Best way to test is NGS. Concordance between IHC and NGS is 90% . Upcoming trials about Role of Parp inhibitors in pts with p53 mutation will give more information about maintenance parp inhibitors in endometrium cancer.”

P53 for endometrial cancer

Source: Amol Akhade/X

Amol Akhade cancer Endometrial cancer OncoDaily Oncology p53 Mutation PARP inhibitors
Special Coverage
Blog
Jul 27, 2025, 18:45
Thanks for Showing Up, Sharing Your Work, and Believing in Collaboration at KCRS25 - KidneyCAN
Blog
Jul 27, 2025, 18:34
Hamza Hashmi: Sharing Ideas, Research, and Debates on Myeloma at the MM Sparks Event in Merida
Blog
Jul 27, 2025, 18:26
Cathy Eng: Always a Pleasure to Listen to Kristen Ciombor Give a Lecture about Immunotherapy in MSI-S CRC
Blog
Jul 27, 2025, 17:40
Aladina Foundation's Psychooncologists Offer a Consultation Outside the Hospital for Free
Opinion
Jul 27, 2025, 17:27
Ian Davis: Why Chemotherapy Has Not Stopped Working in Metastatic Prostate Cancer for More than 20 Years
Blog
Jul 27, 2025, 16:53
Luis E. Raez: The FLASCO “Breaking Barriers” Conference Returns This November
Career
Jul 27, 2025, 16:20
Justin Perry Has Been Promoted to Associate Member at Memorial Sloan Kettering Cancer Center
Blog
Jul 27, 2025, 16:04
Helena Linardou: ESMO Virtual Journal Club – July 2025 Edition
Blog
Jul 27, 2025, 15:57
A Deep Dive Into the Most Important Lung Cancer Trials Presented at ASCO25 - IASLC
Blog
Jul 27, 2025, 15:38
Sergio Cifuentes Canaval: First Meeting of Young Oncologists Group
Science
Jul 27, 2025, 15:14
Talha Badar: PII Trial of CPX-351 and Venetoclax
Insight
Jul 27, 2025, 15:13
Potential Breakthrough for Glioma: Servier’s Therapy Nears EMA Approval - Servier Pharmaceuticals